BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 27115411)

  • 1. Fungal Biofilms: Update on Resistance.
    Borghi E; Borgo F; Morace G
    Adv Exp Med Biol; 2016; 931():37-47. PubMed ID: 27115411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungal biofilm composition and opportunities in drug discovery.
    Reichhardt C; Stevens DA; Cegelski L
    Future Med Chem; 2016 Aug; 8(12):1455-68. PubMed ID: 27485639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal biofilms: From bench to bedside.
    Iñigo M; Del Pozo JL
    Rev Esp Quimioter; 2018 Sep; 31 Suppl 1(Suppl 1):35-38. PubMed ID: 30209921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tackling Fungal Resistance by Biofilm Inhibitors.
    Wu S; Wang Y; Liu N; Dong G; Sheng C
    J Med Chem; 2017 Mar; 60(6):2193-2211. PubMed ID: 28051303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies in the discovery of novel antifungal scaffolds.
    Liu N; Wang C; Su H; Zhang W; Sheng C
    Future Med Chem; 2016 Aug; 8(12):1435-54. PubMed ID: 27463376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida biofilm resistance.
    Mukherjee PK; Chandra J
    Drug Resist Updat; 2004; 7(4-5):301-9. PubMed ID: 15533767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Extracellular Matrix of Fungal Biofilms.
    Mitchell KF; Zarnowski R; Andes DR
    Adv Exp Med Biol; 2016; 931():21-35. PubMed ID: 27271680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highlights in pathogenic fungal biofilms.
    Sardi Jde C; Pitangui Nde S; Rodríguez-Arellanes G; Taylor ML; Fusco-Almeida AM; Mendes-Giannini MJ
    Rev Iberoam Micol; 2014; 31(1):22-9. PubMed ID: 24252828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
    De Brucker K; De Cremer K; Cammue BP; Thevissen K
    Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal therapy with an emphasis on biofilms.
    Pierce CG; Srinivasan A; Uppuluri P; Ramasubramanian AK; López-Ribot JL
    Curr Opin Pharmacol; 2013 Oct; 13(5):726-30. PubMed ID: 24011516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for cell density in antifungal drug resistance in Candida albicans biofilms.
    Perumal P; Mekala S; Chaffin WL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2454-63. PubMed ID: 17502416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biofilms and Antifungal Susceptibility Testing.
    Simitsopoulou M; Chatzimoschou A; Roilides E
    Methods Mol Biol; 2016; 1356():183-97. PubMed ID: 26519074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm.
    Perdoni F; Signorelli P; Cirasola D; Caretti A; Galimberti V; Biggiogera M; Gasco P; Musicanti C; Morace G; Borghi E
    BMC Microbiol; 2015 Oct; 15():248. PubMed ID: 26519193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans biofilms produce antifungal-tolerant persister cells.
    LaFleur MD; Kumamoto CA; Lewis K
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3839-46. PubMed ID: 16923951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic of Fungal Infections Related to Biofilms.
    Sanguinetti M; Posteraro B
    Adv Exp Med Biol; 2016; 931():63-82. PubMed ID: 27300347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Sources as Innovative Solutions Against Fungal Biofilms.
    Girardot M; Imbert C
    Adv Exp Med Biol; 2016; 931():105-25. PubMed ID: 27115410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofilm Exopolysaccharides of Pathogenic Fungi: Lessons from Bacteria.
    Sheppard DC; Howell PL
    J Biol Chem; 2016 Jun; 291(24):12529-12537. PubMed ID: 27129222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies.
    Reales-Calderón JA; Molero G; Gil C; Martínez JL
    Future Med Chem; 2016 Aug; 8(12):1503-20. PubMed ID: 27485839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting efflux pumps to overcome antifungal drug resistance.
    Holmes AR; Cardno TS; Strouse JJ; Ivnitski-Steele I; Keniya MV; Lackovic K; Monk BC; Sklar LA; Cannon RD
    Future Med Chem; 2016 Aug; 8(12):1485-501. PubMed ID: 27463566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.